Michelle Archuleta

Michelle Archuleta PhD is an accomplished professional with extensive experience in data science, bioinformatics, and leadership across multiple sectors. Currently serving as an AI Program Manager at Booz Allen Hamilton since June 2024, Michelle also founded AI Arrive in August 2020, providing specialized consulting in bioinformatics for the pharmaceutical industry. Previous roles include Director of Data Science at RS21, where leadership was demonstrated in addressing complex issues in health and space research, and Director of DataLab at Kimetrica Inc, overseeing critical projects for DARPA. A founder and CEO of multiple companies, including Aipiphany and Doctor Speak, Inc., Michelle has a strong focus on patient empowerment and innovative solutions in healthcare. Educational credentials include a PhD in Chemical Engineering with a focus on biomedical applications and a Bachelor's degree in Chemical Engineering and Mathematics from The University of New Mexico.